One share strategy might not work here.. 😕 You can check last quarter data whereas more than 150000 unique share holder present... And after the announcement of this buyback the number will climbs much more because the price gap is near to 1100/-.. So as per one share strategy it's a risky one.😭😭😭
In one share strategy percentage doesn't give you the right idea, As per data received from sources AARTI DRUGS coming with a tender buyback at a premium of 76% (in price 900/-) sounds good but the price gap is 390/- so which one looks attractive? INDIA MART or AARTI DRUGS. coming back to your point, in the SYMPHONY case the unique shareholder present at the time of the announcement is near about 60000 and the retail quota allocated is 1lcs 50 thousand. So, if more than 50000 new peoples buy the share, the shareholder count stands at the time of record date is 1 lcs 10 thousand. It is still below the allocation mark means the chances of acceptance are 100%. But in this case, the unique shareholder count Is more than the allocated shareholder count at the time of the announcement date and it will shoot up rapidly till the record date comes (evidence: look today's movement)
I write this as per my understanding, Correct me if anyone has better clarification. I am happy to learn from your knowledge.